Additional References

Alvarez-Saavedra M; Saez MA; Kang D; Zoghbi HY; Young JI. 2007. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Hum Mol Genet 16(19):2315-25. [PubMed: 17635839]  [MGI Ref ID J:124365]

Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM. 2006. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol Dis 21(1):217-27. [PubMed: 16087343]  [MGI Ref ID J:104545]

Bissonnette JM; Knopp SJ; Maylie J; Thong T. 2007. Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Auton Neurosci 136(1-2):82-9. [PubMed: 17544925]  [MGI Ref ID J:129856]

Braunschweig D; Simcox T; Samaco RC; LaSalle JM. 2004. X-Chromosome inactivation ratios affect wild-type MeCP2 expression within mosaic Rett syndrome and Mecp2-/+ mouse brain. Hum Mol Genet 13(12):1275-86. [PubMed: 15115765]  [MGI Ref ID J:91193]

Caballero IM; Hendrich B. 2005. MeCP2 in neurons: closing in on the causes of Rett syndrome. Hum Mol Genet 14 Spec No 1:R19-26. [PubMed: 15809268]  [MGI Ref ID J:97524]

Chao HT; Zoghbi HY; Rosenmund C. 2007. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56(1):58-65. [PubMed: 17920015]  [MGI Ref ID J:126964]

Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR. 2007. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Hum Mol Genet 16(6):640-50. [PubMed: 17309881]  [MGI Ref ID J:121717]

Fukuda T; Itoh M; Ichikawa T; Washiyama K; Goto Y. 2005. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64(6):537-44. [PubMed: 15977646]  [MGI Ref ID J:104939]

Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T. 2005. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 37(1):31-40. [PubMed: 15608638]  [MGI Ref ID J:96437]

Ide S; Itoh M; Goto Y. 2005. Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse. Neurosci Lett 386(1):14-7. [PubMed: 15975715]  [MGI Ref ID J:102566]

Jordan C; Francke U. 2006. Ube3a expression is not altered in Mecp2 mutant mice. Hum Mol Genet 15(14):2210-5. [PubMed: 16754645]  [MGI Ref ID J:112026]

Jugloff DG; Logan R; Eubanks JH. 2006. Breeding and maintenance of an Mecp2-deficient mouse model of Rett Syndrome J Neurosci Methods 154(1-2):89-95. [PubMed: 16439027]  [MGI Ref ID J:106418]

Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH. 2008. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Hum Mol Genet 17(10):1386-96. [PubMed: 18223199]  [MGI Ref ID J:135351]

Kriaucionis S; Paterson A; Curtis J; Guy J; Macleod N; Bird A. 2006. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol 26(13):5033-42. [PubMed: 16782889]  [MGI Ref ID J:110323]

Makedonski K; Abuhatzira L; Kaufman Y; Razin A; Shemer R. 2005. MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14(8):1049-58. [PubMed: 15757975]  [MGI Ref ID J:98000]

Metcalf BM; Mullaney BC; Johnston MV; Blue ME. 2006. Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome. Neuroscience 139(4):1449-60. [PubMed: 16549272]  [MGI Ref ID J:108953]

Miralves J; Magdeleine E; Kaddoum L; Brun H; Peries S; Joly E. 2007. High Levels of MeCP2 Depress MHC Class I Expression in Neuronal Cells. PLoS ONE 2(12):e1354. [PubMed: 18159237]  [MGI Ref ID J:130960]

Nan X; Hou J; Maclean A; Nasir J; Lafuente MJ; Shu X; Kriaucionis S; Bird A. 2007. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci U S A 104(8):2709-14. [PubMed: 17296936]  [MGI Ref ID J:125897]

Nelson ED; Kavalali ET; Monteggia LM. 2006. MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol 16(7):710-6. [PubMed: 16581518]  [MGI Ref ID J:107739]

Peddada S; Yasui DH; LaSalle JM. 2006. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet 15(12):2003-14. [PubMed: 16682435]  [MGI Ref ID J:112064]

Russell JC; Blue ME; Johnston MV; Naidu S; Hossain MA. 2007. Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience 150(3):563-74. [PubMed: 17997046]  [MGI Ref ID J:130772]

Santos M; Silva-Fernandes A; Oliveira P; Sousa N; Maciel P. 2007. Evidence for abnormal early development in a mouse model of Rett syndrome. Genes Brain Behav 6(3):277-86. [PubMed: 16848781]  [MGI Ref ID J:135089]

Saywell V; Viola A; Confort-Gouny S; Le Fur Y; Villard L; Cozzone PJ. 2006. Brain magnetic resonance study of Mecp2 deletion effects on anatomy and metabolism. Biochem Biophys Res Commun 340(3):776-83. [PubMed: 16380085]  [MGI Ref ID J:104731]

Schule B; Li HH; Fisch-Kohl C; Purmann C; Francke U. 2007. DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency. Am J Hum Genet 81(3):492-506. [PubMed: 17701895]  [MGI Ref ID J:134837]

Viemari JC; Roux JC; Tryba AK; Saywell V; Burnet H; Pena F; Zanella S; Bevengut M; Barthelemy-Requin M; Herzing LB; Moncla A; Mancini J; Ramirez JM; Villard L; Hilaire G. 2005. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 25(50):11521-30. [PubMed: 16354910]  [MGI Ref ID J:104053]

Viola A; Saywell V; Villard L; Cozzone PJ; Lutz NW. 2007. Metabolic fingerprints of altered brain growth, osmoregulation and neurotransmission in a Rett syndrome model. PLoS ONE 2(1):e157. [PubMed: 17237885]  [MGI Ref ID J:129328]